Lexicon Pharmaceuticals Inc Earnings

The next earnings date for Lexicon Pharmaceuticals Inc is March 18, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Lexicon Pharmaceuticals Inc Earnings

Report DateEstimated Earnings Per Share
03/18/2026$-0.07

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Lexicon Pharmaceuticals Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
10/30/2025---$0100.00%
07/31/2025---$0100.00%
04/30/2025After Market$-0.0732.24%
03/10/2025Before Market$-0.0927.88%
11/06/2024Before Market$-0.18-12.50%
08/01/2024After Market$-0.1710.53%
05/02/2024After Market$-0.200.00%
03/11/2024Before Market$-0.209.09%
11/08/2023Before Market$-0.210.00%
08/03/2023After Market$-0.22-29.41%
05/02/2023After Market$-0.175.56%
03/02/2023After Market$-0.16-23.08%
11/09/2022After Market$-0.137.14%
08/02/2022After Market$-0.160.00%
05/05/2022Before Market$-0.160.00%
02/28/2022Before Market$-0.175.56%
11/03/2021After Market$-0.1611.11%
07/30/2021Before Market$-0.1318.75%
05/06/2021After Market$-0.156.25%
03/10/2021After Market$-0.0485.71%
10/29/2020Before Market$0.70169.23%
07/29/2020After Market$-0.63-3.28%
04/27/2020Before Market$-0.638.70%
03/12/2020Before Market$-0.4837.66%
11/07/2019Before Market$2.11189.04%
07/31/2019Before Market$-0.22-175.00%
05/01/2019Before Market$-0.214.55%
03/13/2019Before Market$-0.1644.83%
11/01/2018Before Market$-0.2621.21%
07/30/2018Before Market$-0.332.94%
05/03/2018Before Market$-0.4011.11%
02/22/2018Before Market$-0.3124.39%
11/08/2017Before Market$-0.2919.44%
08/01/2017Before Market$-0.3325.00%
05/02/2017After Market$-0.3321.43%
03/03/2017Before Market$-0.3140.38%
11/01/2016Before Market$-0.3528.57%
08/04/2016Before Market$-0.377.50%
05/03/2016Before Market$-0.34-13.33%
03/01/2016Before Market$0.76300.00%
11/06/2015Before Market$-0.345.56%
08/07/2015Before Market$-0.2715.63%
04/29/2015After Market$-0.283.45%
03/04/2015Before Market$-0.0480.95%
11/04/2014After Market$-0.350.00%
08/07/2014---$-0.350.00%
05/08/2014---$-0.42-23.53%
02/28/2014---$-0.2144.74%
11/12/2013---$-0.42-320.00%
07/30/2013---$-0.42-13.51%
05/10/2013---$-0.350.00%
02/21/2013---$-0.355.41%
11/06/2012---$-0.42-2.44%
07/31/2012---$-0.3516.67%
05/03/2012---$-0.4214.29%
02/22/2012---$-0.70-20.69%
11/01/2011---$-0.568.20%
08/08/2011---$-0.568.20%
05/03/2011---$-0.63-28.57%
02/24/2011---$-0.4912.50%
11/05/2010---$-0.560.00%
08/09/2010---$-0.4912.50%
05/10/2010---$-0.91-85.71%
02/23/2010---$-0.917.14%
10/27/2009---$-0.98---
07/28/2009---$-1.056.25%
04/28/2009---$-1.12-23.08%
02/25/2009---$-0.7735.29%
10/30/2008---$-1.19-7.21%
07/29/2008---$-1.052.78%
04/29/2008---$-0.910.00%
03/06/2008---$-0.6327.59%
10/30/2007---$-0.9810.91%
07/31/2007---$-1.1922.73%
05/01/2007---$-1.6816.42%
02/21/2007---$-1.3319.88%
10/31/2006---$-1.4018.13%
08/01/2006---$-1.826.19%
05/02/2006---$-1.1911.85%
02/22/2006---$0.63142.31%
11/01/2005---$-1.5415.38%
07/28/2005---$-1.6121.08%
04/28/2005---$-1.4721.39%
02/24/2005---$-0.0791.03%
10/28/2004---$-1.617.47%
07/29/2004---$-1.827.14%
04/29/2004---$-1.751.69%
02/19/2004---$-1.336.99%
10/30/2003---$-1.4023.08%
07/31/2003---$-2.034.69%
05/01/2003---$-1.967.55%
02/19/2003---$-1.5424.14%
10/30/2002---$-1.89-5.00%
08/07/2002---$-1.685.08%
05/09/2002---$-1.5422.22%
03/07/2002---$-1.1211.11%
11/06/2001---$-0.4947.87%
08/07/2001---$-1.40-38.61%
05/08/2001---$-0.7726.67%
03/07/2001---$-0.7711.49%
10/26/2000---$-0.2170.00%
07/27/2000---$-0.56-27.27%

More About Lexicon Pharmaceuticals Inc

Country
USA
Full Time Employees
103

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company offers Sotagliflozin, an orally-delivered small molecule drug to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits in adults with heart failure or type 2 diabetes mellitus, chronic kidney disease or CKD, and other cardiovascular risk factors. Its orally-delivered small molecule drug candidates under development include sotagliflozin for the treatment of hypertrophic cardiomyopathy or HCM and type 1 diabetes that is in Phase 3 clinical trial; LX9211, which has completed Phase II clinical trials for the treatment of neuropathic pain; and LX9851 for the treatment of obesity and associated cardiometabolic disorders, as well as for weight management. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Lexicon Pharmaceuticals Inc Earnings” Can Refer to the Lexicon Pharmaceuticals Inc Earnings Date

Some people say “Lexicon Pharmaceuticals Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Lexicon Pharmaceuticals Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Lexicon Pharmaceuticals Inc Stock on the Earnings Date

If you own Lexicon Pharmaceuticals Inc stock (LXRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Lexicon Pharmaceuticals Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Lexicon Pharmaceuticals Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Lexicon Pharmaceuticals Inc Earnings

You can contact us any time if you would like to ask questions about Lexicon Pharmaceuticals Inc earnings or anything else related to the stock market.